Debora Chiodi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Debora Chiodi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Phil S. Baran
Department of Chemistry, Scripps Research, La Jolla, USA
4 shared publications - Yoshihiro Ishihara
Genesis Molecular AI 4930 Directors Place Suite 200
4 shared publications Fabian Schneider
Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
2 shared publicationsKelly J. Eberle
Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
2 shared publicationsMasato Saito
Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
2 shared publicationsYou-Chen Lin
Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
2 shared publications
Latest Publications
- 18 October 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (21) , 25041-25065
gem -Dimethylcarbinol: A tert -Butyl Bioisostere with Greatly Reduced Lipophilicity
The tert-butyl group is a large substituent that could be useful in some contexts for filling protein pockets, but this highly lipophilic group typically worsens the ADMET properties of the parent scaffold. Although many bioisosteres of tert-butyl are similarly lipophilic, gem-dimethylcarbinol could be a bioisostere with greatly reduced lipophilicity, bestowing balanced properties to a lead compound. This could benefit multi-parameter optimization that includes solubility, permeability, and in vitro clearance. Although one downside of installing the gem-dimethylcarbinol group is greater efflux, making it a poor motif for CNS applications, small structural modifications could mitigate this issue. The gem-dimethylcarbinol group is not chemically reactive under physiological conditions, is not a blacklisted toxicophore, and is present in a small but growing number of approved drugs. Furthermore, the simplicity of its installation in organic chemistry makes it an attractive option as a tert-butyl bioisostere with great opportunities in medicinal chemistry.
- 18 October 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (21) , 25041-25065
gem -Dimethylcarbinol: A tert -Butyl Bioisostere with Greatly Reduced Lipophilicity
The tert-butyl group is a large substituent that could be useful in some contexts for filling protein pockets, but this highly lipophilic group typically worsens the ADMET properties of the parent scaffold. Although many bioisosteres of tert-butyl are similarly lipophilic, gem-dimethylcarbinol could be a bioisostere with greatly reduced lipophilicity, bestowing balanced properties to a lead compound. This could benefit multi-parameter optimization that includes solubility, permeability, and in vitro clearance. Although one downside of installing the gem-dimethylcarbinol group is greater efflux, making it a poor motif for CNS applications, small structural modifications could mitigate this issue. The gem-dimethylcarbinol group is not chemically reactive under physiological conditions, is not a blacklisted toxicophore, and is present in a small but growing number of approved drugs. Furthermore, the simplicity of its installation in organic chemistry makes it an attractive option as a tert-butyl bioisostere with great opportunities in medicinal chemistry.
- Open Access
Sequential One-Pot Oxo-Re(V)-Catalyzed Meyer–Schuster Rearrangement of Propargylic Alcohols Followed by the Conjugate Addition of Gilman Organocuprates and Hydride Reduction or by the Reaction with Hydrazine Hydrochloride to Give Pyrazoles
One-pot protocols leading to target products in two or more sequential reactions, without the separation and isolation of intermediate products, are powerful synthetic tools. In fact, they surpass usual procedures based on single-step reactions in terms of efficiency, cost, and green aspects. The appeal of such methodologies is further increased with the use of catalysts, which makes the process easier and more efficient, minimizing unwanted byproducts. In this context, this paper describes three new one-pot protocols, based on an oxo-Re(V)-catalyzed Meyer–Schuster rearrangement of different secondary propargylic alcohols to the corresponding α,β-unsaturated ketones. These products, without isolation, subsequently, can undergo the 1,4-conjugate addition of a soft Gilman copper nucleophile or the intramolecular cyclocondensation with hydrazine hydrochloride to pyrazoles. Moreover, the ketone formed by the addition of a Gilman reagent can further be reduced in situ with LiAlH4 to the corresponding secondary alcohol. The remarkable aspects of these novel procedures involving two and three one-pot consecutive steps are the high overall yields, the readily available reaction conditions, and the compatible presence of two transition metallic species in the same reaction medium.
Open AccessSequential One-Pot Oxo-Re(V)-Catalyzed Meyer–Schuster Rearrangement of Propargylic Alcohols Followed by the Conjugate Addition of Gilman Organocuprates and Hydride Reduction or by the Reaction with Hydrazine Hydrochloride to Give Pyrazoles
One-pot protocols leading to target products in two or more sequential reactions, without the separation and isolation of intermediate products, are powerful synthetic tools. In fact, they surpass usual procedures based on single-step reactions in terms of efficiency, cost, and green aspects. The appeal of such methodologies is further increased with the use of catalysts, which makes the process easier and more efficient, minimizing unwanted byproducts. In this context, this paper describes three new one-pot protocols, based on an oxo-Re(V)-catalyzed Meyer–Schuster rearrangement of different secondary propargylic alcohols to the corresponding α,β-unsaturated ketones. These products, without isolation, subsequently, can undergo the 1,4-conjugate addition of a soft Gilman copper nucleophile or the intramolecular cyclocondensation with hydrazine hydrochloride to pyrazoles. Moreover, the ketone formed by the addition of a Gilman reagent can further be reduced in situ with LiAlH4 to the corresponding secondary alcohol. The remarkable aspects of these novel procedures involving two and three one-pot consecutive steps are the high overall yields, the readily available reaction conditions, and the compatible presence of two transition metallic species in the same reaction medium.
- 19 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (2) , 1207-1230
Parallels between the chloro and methoxy groups for potency optimization
There are parallels between Cl and OCH 3 in the types of ligand–protein interactions they engage in. The dual electrostatic versatility of these two substituents renders them useful scouts to probe protein pockets for potency optimization.
- 19 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (2) , 1207-1230
Parallels between the chloro and methoxy groups for potency optimization
There are parallels between Cl and OCH 3 in the types of ligand–protein interactions they engage in. The dual electrostatic versatility of these two substituents renders them useful scouts to probe protein pockets for potency optimization.
- 15 April 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (8) , 7889-7913
Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery
Among the smaller substituents in the medicinal chemist's toolbox, the hydroxy (OH) group can bestow one of the largest impacts in the drug-like properties of a molecule. A previous study showed that an H-to-OH structural modification effectively decreases lipophilicity, increases solubility, and decreases hERG inhibition. Despite these benefits, an OH group is not always recommended in drug molecules because it presents a metabolic "soft spot" for oxidation and glucuronidation in primary and secondary alcohols. Furthermore, the OH group presents challenges in permeability. In contrast, tertiary alcohols (3° ROH) often display an improved metabolic profile because oxidation at the 3° ROH is not possible, and the geminal alkyl groups could sterically shield the OH group from glucuronidation and permeability challenges. Through a series of matched molecular pairs, this Perspective highlights the 3° ROH as a motif that can reap the benefits but minimize the drawbacks of hydroxy groups in drug discovery.
- 15 April 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (8) , 7889-7913
Tertiary Alcohol: Reaping the Benefits but Minimizing the Drawbacks of Hydroxy Groups in Drug Discovery
Among the smaller substituents in the medicinal chemist's toolbox, the hydroxy (OH) group can bestow one of the largest impacts in the drug-like properties of a molecule. A previous study showed that an H-to-OH structural modification effectively decreases lipophilicity, increases solubility, and decreases hERG inhibition. Despite these benefits, an OH group is not always recommended in drug molecules because it presents a metabolic "soft spot" for oxidation and glucuronidation in primary and secondary alcohols. Furthermore, the OH group presents challenges in permeability. In contrast, tertiary alcohols (3° ROH) often display an improved metabolic profile because oxidation at the 3° ROH is not possible, and the geminal alkyl groups could sterically shield the OH group from glucuronidation and permeability challenges. Through a series of matched molecular pairs, this Perspective highlights the 3° ROH as a motif that can reap the benefits but minimize the drawbacks of hydroxy groups in drug discovery.
- 1 March 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (10) , 6444-6448
Total Synthesis of Dynobactin A
The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis enlists a singular aziridine ring opening strategy to access the two disparate β-aryl-branched amino acids present within this complex decapeptide. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 16 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogues for medicinal chemistry studies.
- 1 March 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (10) , 6444-6448
Total Synthesis of Dynobactin A
The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis enlists a singular aziridine ring opening strategy to access the two disparate β-aryl-branched amino acids present within this complex decapeptide. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 16 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogues for medicinal chemistry studies.
- Open Access
- 26 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Total Synthesis of Dynobactin A
The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis capitalizes on the hidden symmetry present in this complex decapeptide by enlisting an aziridine ring opening strategy to access b-branched amino acids. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 14 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogs for medicinal chemistry studies.
- 26 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessTotal Synthesis of Dynobactin A
The first total synthesis of the potent antimicrobial agent dynobactin A is disclosed. This synthesis capitalizes on the hidden symmetry present in this complex decapeptide by enlisting an aziridine ring opening strategy to access b-branched amino acids. Featuring a number of unique maneuvers to navigate inherently sensitive and epimerizable functional groups, this convergent approach proceeds in only 14 steps (LLS) from commercial materials and should facilitate the synthesis of numerous analogs for medicinal chemistry studies.
- Top Cited Papers
- 4 April 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (8) , 5305-5331
“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
- 4 April 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (8) , 5305-5331
Top Cited Papers“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
- 4 August 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (32) , 14458-14462
Atroposelective Total Synthesis of Darobactin A
A concise, modular synthesis of the novel antibiotic darobactin A is disclosed. The synthesis successfully forges the hallmark strained macrocyclic ring systems in a sequential fashion. Key transformations include two atroposelective Larock-based macrocyclizations, one of which proceeds with exquisite regioselectivity despite bearing an unprotected alkyne. The synthesis is designed with medicinal chemistry considerations in mind, appending key portions of the molecule at a late stage. Requisite unnatural amino acid building blocks are easily prepared in an enantiopure form using C-H activation and decarboxylative cross-coupling tactics.
- 4 August 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (32) , 14458-14462
Atroposelective Total Synthesis of Darobactin A
A concise, modular synthesis of the novel antibiotic darobactin A is disclosed. The synthesis successfully forges the hallmark strained macrocyclic ring systems in a sequential fashion. Key transformations include two atroposelective Larock-based macrocyclizations, one of which proceeds with exquisite regioselectivity despite bearing an unprotected alkyne. The synthesis is designed with medicinal chemistry considerations in mind, appending key portions of the molecule at a late stage. Requisite unnatural amino acid building blocks are easily prepared in an enantiopure form using C-H activation and decarboxylative cross-coupling tactics.
- 13 May 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 143 (20) , 7859-7867
N-Ammonium Ylide Mediators for Electrochemical C–H Oxidation
The site-specific oxidation of strong C(sp3)–H bonds is of uncontested utility in organic synthesis. From simplifying access to metabolites and late-stage diversification of lead compounds to truncating retrosynthetic plans, there is a growing need for new reagents and methods for achieving such a transformation in both academic and industrial circles. One main drawback of current chemical reagents is the lack of diversity with regard to structure and reactivity that prevents a combinatorial approach for rapid screening to be employed. In that regard, directed evolution still holds the greatest promise for achieving complex C–H oxidations in a variety of complex settings. Herein we present a rationally designed platform that provides a step toward this challenge using N-ammonium ylides as electrochemically driven oxidants for site-specific, chemoselective C(sp3)–H oxidation. By taking a first-principles approach guided by computation, these new mediators were identified and rapidly expanded into a library using ubiquitous building blocks and trivial synthesis techniques. The ylide-based approach to C–H oxidation exhibits tunable selectivity that is often exclusive to this class of oxidants and can be applied to real-world problems in the agricultural and pharmaceutical sectors.
- 13 May 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 143 (20) , 7859-7867
N-Ammonium Ylide Mediators for Electrochemical C–H Oxidation
The site-specific oxidation of strong C(sp3)–H bonds is of uncontested utility in organic synthesis. From simplifying access to metabolites and late-stage diversification of lead compounds to truncating retrosynthetic plans, there is a growing need for new reagents and methods for achieving such a transformation in both academic and industrial circles. One main drawback of current chemical reagents is the lack of diversity with regard to structure and reactivity that prevents a combinatorial approach for rapid screening to be employed. In that regard, directed evolution still holds the greatest promise for achieving complex C–H oxidations in a variety of complex settings. Herein we present a rationally designed platform that provides a step toward this challenge using N-ammonium ylides as electrochemically driven oxidants for site-specific, chemoselective C(sp3)–H oxidation. By taking a first-principles approach guided by computation, these new mediators were identified and rapidly expanded into a library using ubiquitous building blocks and trivial synthesis techniques. The ylide-based approach to C–H oxidation exhibits tunable selectivity that is often exclusive to this class of oxidants and can be applied to real-world problems in the agricultural and pharmaceutical sectors.